Categories AlphaGraphs, Earnings, Technology

Intel (INTC) Q2 revenue up 20%; earnings top view

Chipmaker Intel Corporation (NASDAQ: INTC) reported a 20% growth in second-quarter revenues, reflecting the strong demand for cloud services during the COVID-related shutdown. However, the stock declined on Thursday evening due to the weak guidance issued by the management.

Intel (INTC) Q2 revenue up 20%; earnings top view

Earnings, excluding special items, moved up to $1.23 per share from $1.06 per share in the second quarter of last year. Unadjusted net income rose to $5.1 billion or $1.19 per share from $4.2 billion or $0.92 per share a year earlier. The bottom line topped expectations.


Looking forward to listening to management/analysts’ comments on Q2 results? Stay tuned here for Intel’s Q2 2020 earnings call transcript 


At $19.7 billion, total revenues were up 20% year-over-year and above analysts’ consensus estimate. Intel’s stock dropped during Thursday’s after-hours trading, after closing the regular session lower.

“In our increasingly digital world, Intel technology is essential to nearly every industry on this planet. We have an incredible opportunity to enrich lives and grow this company with a continued focus on innovation and execution,” said CEO Bob Swan.

Also Read:  DISH Q2 2020 Earnings: Key quarterly highlights

Most Popular

Baidu (BIDU) Q2 earnings rise unexpectedly; stock falls

https://www.youtube.com/watch?v=50yUaLybUnA&t=667s China-based internet search firm Baidu Inc. (NASDAQ: BIDU) reported financial results for the second quarter of 2020 on Thursday after the market's close. Earnings exceeded analysts’ expectations, but the

Applied Materials (AMAT) tops Q3 2020 targets; provides Q4 outlook

Applied Materials' (NASDAQ: AMAT) earnings and revenue for the third quarter exceeded the market's views. Adjusted EPS of $1.06 and revenue of $4.40 billion in Q3, grew 43% and 23%,

Is Altimmune (ALT) stock a buy right now?

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment of COVID-19. While these companies

Top